Alfasigma
is an Italy-based pharmaceutical company that researches and develops novel therapeutics for diseases such as metabolic and digestive disorders... Read moreAlfasigma
is an Italy-based pharmaceutical company that researches and develops novel therapeutics for diseases such as metabolic and digestive disorders... Read more
News
Oct 03, 2024
Born2Invest
Alfasigma: Alfasigma Gets Green Light for Commercialization of Jyseleca in Europe
Aug 09, 2024
Endpoints News
Alfasigma: Alfasigma's PBC treatment Ocaliva to face an FDA adcomm in September
Nov 08, 2023
BioSpace
Alfasigma: Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc.
Nov 08, 2023
Pharamceutical Technology
Alfasigma: Alfasigma opens new doors in the US with Intercept acquisition
Nov 01, 2023
Born2Invest
Alfasigma: Alfasigma Signs an Agreement with Galapagos to Buy Jyseleca Drug Assets
Oct 31, 2023
Endpoints News
Alfasigma: Galapagos plans to transfer Jyseleca to Alfasigma for 50M upfront and reduce workforce
Oct 31, 2023
European Biotechnology
Alfasigma: Alfasigma SpA set to take over Galapagos programme
Sep 28, 2023
MarketScreener
Alfasigma: INTERCEPT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intercept Pharmaceuticals, Inc. - ICPT
Sep 28, 2023
MarketScreener
Alfasigma: GlobalData : Intercept acquisition by Alfasigma reflects NASH failure, says GlobalData
Sep 26, 2023
STAT News
Alfasigma: STAT+: Intercept, once a biotech trailblazer, sells itself for less than $1 billion
Alfasigma Competitors
1
2
3
4
5
6
7
8
9
10